♟ A Win-Both-Ways Trade on Biogen: Strategy Revealed

This sets us up PERFECTLY for my Win-Both-Ways strategy. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sorry for the Delay! Our bad! Our latest Trade of the Day issue got stuck in the email queue (or so the web guy tells us 🙄), so you may not have received last night's issue. But it's critical that you see this, as it outlines a Win-Both-Ways Trade surrounding a major market-moving event. Get all the details below...

Brought to you by The War Room

A Win-Both-Ways Trade on Biogen: Strategy Revealed

Bryan Bottarelli, Head Trade Tactician, Monument Traders Alliance

This sets us up PERFECTLY for my Win-Both-Ways strategy.

Turn Your Downtime Into Cash! Real people have made big money trading from home... $3,000... $5,500... and even $12,000... in ONE day! (All with fast 30%... 55%... and even 120% gains - often before they finish their first cup of coffee!) Many had NO experience... It's all thanks to the 15-Minute Workday... And for a limited time - you can learn the secret... Click Here Now (No Credit Card Required)

Overheard Inside The War Room As pessimism toward Robinhood remains, both SCHW and TIGR remain in play. Trade of the Day members who bought TBIO (recommended here on December 3) are up 50% as it rides the MRNA wave. Members locked in a quick 15-minute winner this morning on PLNT. Click here to start profiting with us!

I'd like to take a moment and outline the fascinating story that's currently unfolding on Biogen (Nasdaq: BIIB). As I'm sure you know, there is currently no cure for Alzheimer's disease. But now, as there hasn't been a treatment for the disease in 18 years, the FDA is faced with a major decision on Biogen's drug aducanumab. If the drug is approved, it could generate more than $10 billion in sales per year, giving Biogen complete control of the Alzheimer's market for years. If the drug is not approved, Biogen shares could crater. And the FDA's expert panel has already voted (twice) to stop late-stage trials due to the ineffectiveness of a drug. But the interesting thing is this... New data always seems to pop up, which gives certain drugs a second and third chance at success. The FDA has now requested new data needed for another review, pushing the deadline out to June 7. So clearly, the FDA is caught in the middle... Yes, it absolutely wants an approved Alzheimer's drug on the market, and Biogen is really the only company that's remotely close to making one (Eli Lilly has a drug called donanemab in early-stage trials, but more information won't become known until March). However, based on precedent - and the FDA's decision-making process based on the advice of its expert panels - it's reasonable to assume that Biogen will be disappointed. But what's clear to me is that no matter what happens - approval or rejection - Biogen stock is on for a major, major move. This sets us up PERFECTLY for my Win-Both-Ways strategy. Action Plan: With the FDA decision expected in early June, I like the idea of owning a two-sided Biogen call and put combo that expires in July. That way, no matter which direction Wall Street overreacts to the Biogen news, you'll be properly positioned. I will be releasing this strategy to all of my paid Trade of the Day Plus members later this month. If you'd like to receive this new trade the moment I release it, I invite you to "level up" and join Trade of the Day Plus today! Yours in smart speculation,

Bryan Bottarelli, Head Trade Tactician Monument Traders Alliance

Recent War Room Winners PLNT 2/8/2021 15.56% COST 2/8/2021 13.64% AAPL 2/8/2021 15.24% ULTA 2/5/2021 41.18% DG 2/5/2021 29.27% Biggest War Room Winners BG 5/26/2020 320.00% DIS 10/13/2020 198.81% FDX 9/18/2019 188.49% NUGT 8/17/2020 179.31% FSLR 10/28/2020 160.15% Fastest War Room Winners LMND (4 minutes) 12/7/2020 36.67% ROKU (4 minutes) 9/10/2019 53.62% MCD (5 minutes) 1/8/2020 24.39% OKTA (5 minutes) 1/6/2020 27.50% RGR (8 minutes) 1/6/2021 73.33% WMT (Fastest double) 1 hour, 20 minutes 7/7/2020 121.12% To start pocketing gains like these, click here!

WAR Room Testimonials

JoAnn B. February 8, 2021, 9:58 a.m. In PLNT at $4.50, out at $5.30 for almost 18% return. Not bad for 15 minutes worth of work. Thx BB.

AnamCara February 8, 2021, 11:15 a.m. In AAPL at $3.22 out at $3.65, 13% in an hour! How 'bout dem Apples! 🍎 😀 Thanks Bryan!

Did This Stock-Picking Genius Uncover 2021's BIGGEST Tech Breakthrough... While Fly-Fishing in Alaska?! This financial wizard traveled to remote Alaska... meeting with ultra-wealthy CEOs and businessmen... And oddly, it was on this elite fishing trip that he first glimpsed the KEY to a coming $1 TRILLION market disruption... Here's the true story of his remarkable discovery... and the tiny company that could soar from it.

Take Trade of the Day Wherever You Go! Like trading memes? Like chart formations? Follow us on Instagram!   Want to get our trade alerts on social media? Follow us on Facebook!   Want to get our urgent alerts? Follow us on Twitter!

You are receiving this email because you subscribed to Trade of the Day. To unsubscribe from Trade of the Day, click here. Ready to start investing? Click here now. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 Website: MTATradeoftheDay.com Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day. © 2021 Monument Traders Alliance All Rights Reserved

Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.